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A 57-year-old woman was treated with peritoneal dialysis for
15 years, after which ultra-filtration failure occurred.
Permeability testing of the peritoneum was suggestive for
sclerosing peritonitis. She was switched to hemodialysis.
Half a year later she developed clinically manifest ascites.
Diagnostic paracentesis revealed milky ascites resembling
chylous ascites (Figure 1). However, even after appropriate
dilutions no triglycerides were detected. Further evaluation of
the ascites was consistent with an exudate, pH 7.54 contain-
ing 2.42mmol/l calcium and 5.58mmol/l phosphorus. Serum
calcium and phosphate levels were normal; parathyroid
hormone (PTH) level was 42 pmol/l.
What is the cause of this patient’s milky ascites?
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Figure 1 |Milky ascites.
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The Diagnosis 7 Calcifying sclerosing peritonitis
Because of the milky aspect of the fluid further tests
were done, which showed calcium-hydroxyphosphate–apatite
crystals (Figure 2) and massive amounts of colloidal calcium-
phosphate–fetuin-A complexes, or calciprotein particles
(CPPs).
Calcifying sclerosing peritonitis is a particularly severe
form of dialysis-associated calcification.1 Tissue calcification
in chronic kidney disease (CKD) patients is driven by an
imbalanced mineral homeostasis. The elevated calcium and
phosphate concentrations result in a chemical precipitation
reaction that can lead to mineral deposition in the extra-
cellular fluid (calcium-hydroxyphosphate–apatite crystals).
Other calcification inducers in CKD patients are an increased
PTH level and excessive treatment with vitamin D.2 A
number of calcium-regulatory factors control and prevent
unwanted extra-osseous calcification: Matrix Gla protein acts
locally, for example, with the elastic lamellae of arteries
preventing media calcification, while pyrophosphate and
the plasma protein fetuin-A act systemically in blood and
tissue fluids. Fetuin-A is a liver-derived plasma protein that
has the ability to prevent the precipitation of basic calcium
phosphates from supersaturated solutions by the two-step
formation of CPPs, which may serve as a transport form of
otherwise insoluble mineral debris. Acidic plasma proteins,
including albumin, greatly stabilize CPPs after the initial
formation.
In general, dialysis patients often suffer combined
deficiency in fetuin-A and albumin, which can explain why
these patients are at a much higher risk of calcification and
associated cardiovascular morbidity and mortality.3
Although our patient had a well-controlled calcium-
phosphorus product, the presence of high inflammatory
activity during her sclerosing peritonitis may have evoked
the precipitation of the calcium-hydroxyphosphate–apatite
crystals by lowering the serum fetuin-A, which is a negative
acute-phase protein.
She was treated with tamoxifen while her calcium-
phosphorus levels were further improved. At 2 years of
follow-up, she remains well with a stable amount of ascites.
REFERENCES
1. Heiss A, Eckert T, Aretz A et al. Hierarchical role of fetuin-A and acidic
serum proteins in the formation and stabilization of calcium phosphate
particles. J Biol Chem 2008; 283: 14815–14825.
2. Kuzniar J, Porazko T, Klinger M. Relationship between fetuin-A
concentration elevated levels of inflammatory markers, and arterial
wall stiffness in end-stage kidney disease. J Renal Nutr 2008;
18: 83–86.
3. Ketteler M, Bongartz P, Westenfeld R et al. Association of low fetuin-A
(AHSG) concentrations in serum with cardiovascular mortality in patients
on dialysis: a cross-sectional study. Lancet 2003; 361: 827–833.
Figure 2 |Calcium-hydroxyphosphate-apatite crystals.
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